New Zealand markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.8000-0.1000 (-3.45%)
At close: 04:00PM EST
2.9400 +0.14 (+5.00%)
After hours: 05:04PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts5355
Avg. Estimate-0.26-0.25-0.96-0.82
Low estimate-0.3-0.29-0.99-1.07
High estimate-0.2-0.19-0.92-0.43
Year ago EPS-0.05-0.16-0.09-0.96
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts5466
Avg. Estimate12.68M15.68M52.04M75.96M
Low estimate12M12.9M49.42M60.9M
High estimate13.23M19.92M62M82.07M
Year ago sales12.31M13.19M43.52M52.04M
Sales growth (year/est)3.00%18.90%19.60%46.00%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.23-0.26-0.23-0.24
Actual EPS-0.05-0.16-0.25-0.31
Difference0.180.1-0.02-0.07
Surprise %78.30%38.50%-8.70%-29.20%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.26-0.25-0.96-0.82
7 days ago-0.26-0.25-0.96-0.82
30 days ago-0.22-0.18-0.88-0.74
60 days ago-0.18-0.18-0.88-0.65
90 days ago-0.19-0.2-0.79-0.72
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCULIndustrySector(s)S&P 500
Current qtr.-420.00%N/AN/AN/A
Next qtr.-56.20%N/AN/AN/A
Current year-966.70%N/AN/AN/A
Next year14.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A